Title : LY294002 potentiates the anti-cancer effect of oxaliplatin for gastric cancer via death receptor pathway.

Pub. Date : 2011 Jan 14

PMID : 21245990






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 LY294002 promoted oxaliplatin-induced Fas ligand (FasL) expression, Fas-associated death domain protein recruitment, caspase-8, Bid, and caspase-3 activation, and the short form of cellular caspase-8/FLICE-inhibitory protein (c-FLIP(S)) inhibition. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one caspase 3 Homo sapiens
2 In vivo, LY294002 inhibited oxaliplatin-induced activation of Akt and NFkappaB, and increased oxaliplatin-induced expression of FasL, inhibition of c-FLIP(S), and activation of caspase-8, Bid, and caspase-3. 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one caspase 3 Homo sapiens